rs10914539: Understanding Its Association with Multiple Sclerosis
The rs10914539 variant is a single nucleotide polymorphism located in a non-coding, intergenic region of the human genome. It has been identified through genome-wide association studies as having a statistical link to the risk of developing multiple sclerosis, particularly in individuals of European ancestry.
What each genotype means
Baseline multiple sclerosis risk
This genotype represents the common, non-risk version of this variant. Research indicates that individuals with this profile do not carry the specific genetic association linked to increased multiple sclerosis susceptibility at this location.
This is the most common genotype in populations of European ancestry.
Slightly elevated risk profile
Carrying one copy of the risk-associated allele may contribute to a slightly higher statistical risk of developing multiple sclerosis compared to those without it. Because this variant is located in a non-coding region, its exact biological impact on disease development remains a subject of ongoing scientific investigation.
This heterozygous genotype is found in a significant portion of individuals of European ancestry.
Increased multiple sclerosis risk
Carrying two copies of this risk-associated allele is statistically linked to a higher predisposition for multiple sclerosis in European populations. This association is part of a complex genetic architecture, and having this genotype does not mean an individual will develop the condition.
This homozygous genotype is less common than the others but is observed specifically within European ancestry groups.
What is rs10914539?
The rs10914539 variant is a specific change in the DNA sequence, known as a single nucleotide polymorphism (SNP), where one nucleotide is substituted for another. This particular SNP is classified as intergenic, meaning it resides in the vast stretches of DNA located between protein-coding genes. Because it does not sit within a gene that provides instructions for making a protein, it is often referred to as a non-coding variant. Scientists study these regions because they frequently contain regulatory elements—switches that control when, where, and how much of a nearby gene is expressed. While the exact functional mechanism of rs10914539 remains under investigation, its presence is tracked by researchers to better understand the complex genetic architecture that contributes to autoimmune conditions.
Association with Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, inflammatory, and autoimmune disease of the central nervous system. Over the past two decades, large-scale genome-wide association studies (GWAS) have successfully identified hundreds of genetic variants that contribute to MS susceptibility. The rs10914539 variant has been highlighted in these studies as a marker associated with MS risk. The evidence for this association is considered moderate, as it is one of many variants that collectively influence disease predisposition. It is important to note that having this variant does not mean an individual will develop MS; rather, it represents a small, incremental change in the statistical probability of disease development. Research continues to focus on how such non-coding variants might influence the behavior of immune cells or the resilience of the central nervous system.
Population Frequency and Ancestry
Genetic variants often show significant differences in frequency across different ancestral populations, a phenomenon known as population stratification. The rs10914539 variant is primarily noted for its association with MS risk in European populations. Because many early and large-scale GWAS were conducted using cohorts of European descent, the data for this variant is most robust within that group. In other populations, the frequency of this variant may differ, or it may not show the same statistical association with MS. This highlights the importance of multi-ancestry studies in genomics, as findings in one group cannot always be generalized to others. Researchers are actively working to expand genetic databases to include more diverse populations to ensure that our understanding of MS risk factors is comprehensive and equitable.
Interpreting Genetic Information
If you have learned that you carry the rs10914539 variant, it is essential to understand that this is not a diagnostic test for multiple sclerosis. MS is a multifactorial disease, meaning it is influenced by a combination of numerous genetic factors, environmental exposures, and lifestyle elements. A single SNP, especially one in a non-coding region, provides only a tiny fraction of the information regarding an individual's health. This information is intended for educational purposes and should not be used to make medical decisions or to predict personal health outcomes. If you have concerns about your health or family history of autoimmune conditions, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can provide context based on your full clinical picture rather than focusing on a single genetic marker.
How common is this variant?
The rs10914539 variant is considered an ancestry-specific marker, with its frequency and association with multiple sclerosis primarily documented in populations of European descent.
Frequently asked questions
Does having the rs10914539 variant mean I will get MS?
No. This variant is only one of many genetic factors associated with MS risk. Most people who carry this variant will never develop the disease, as MS is influenced by a complex interplay of genetics and environment.
Is rs10914539 a diagnostic test for multiple sclerosis?
No, it is not a diagnostic test. MS is diagnosed by neurologists based on clinical symptoms, physical examinations, and imaging studies like MRIs, not by genetic testing alone.
Why is this variant called intergenic?
It is called intergenic because it is located in the DNA sequence between two known genes. It does not code for a protein itself, but it may play a role in regulating the activity of nearby genes.
Can I change my risk if I have this variant?
Genetic variants are inherited and cannot be changed. However, maintaining a healthy lifestyle and discussing your family medical history with a doctor are the best ways to manage your overall health.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10914539?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant in the PAM gene is associated with an increased risk of type 2 diabetes mellitus in the Chinese population.
This variant in the CASP3 gene is associated with susceptibility to prostate cancer and adverse clinical outcomes.
This variant in the CASP9 gene is identified as a candidate marker for prostate cancer susceptibility.
This variant in the PAM gene is linked to an increased risk of type 2 diabetes mellitus, particularly in patients without retinopathy.
This variant in the NKX3-1 gene is associated with prostate cancer susceptibility and poor prognosis.
This variant in the BCL-2 gene is a candidate marker for prostate cancer susceptibility and is associated with poor prognosis when combined with other markers.